Switch to:
Biomarin Pharmaceutical Inc (NAS:BMRN)
EV/EBITDA
-643.58 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Biomarin Pharmaceutical Inc's enterprise value is $20,261.2 Mil. Biomarin Pharmaceutical Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Dec. 2014 was $-31.5 Mil. Therefore, Biomarin Pharmaceutical Inc's EV/EBITDA ratio for today is -643.58.

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Biomarin Pharmaceutical Inc's stock price is $129.14. Biomarin Pharmaceutical Inc's earnings per share for the trailing twelve months (TTM) ended in Dec. 2014 was $-0.92. Therefore, Biomarin Pharmaceutical Inc's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Biomarin Pharmaceutical Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=20261.230/-31.482
=-643.58

Biomarin Pharmaceutical Inc's current Enterprise Value is $20,261.2 Mil.
Biomarin Pharmaceutical Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Dec. 2014 was -13.495 (Mar. 2014 ) + -4.829 (Jun. 2014 ) + 26.559 (Sep. 2014 ) + -39.717 (Dec. 2014 ) = $-31.5 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Biomarin Pharmaceutical Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=129.14/-0.921
=

Biomarin Pharmaceutical Inc's share price for today is $129.14.
Biomarin Pharmaceutical Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Dec. 2014 was -0.27 (Mar. 2014 ) + -0.23 (Jun. 2014 ) + 0.05 (Sep. 2014 ) + -0.471 (Dec. 2014 ) = $-0.92.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Biomarin Pharmaceutical Inc Annual Data

Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14
ev2ebitda -17.86-101.46-325.1726.4558.82180.644,674.71-94.71-83.82-414.26

Biomarin Pharmaceutical Inc Quarterly Data

Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14Dec14
ev2ebitda -120.69-94.71-95.76-104.69-88.93-83.82-96.34-90.68-314.37-414.26
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK